LUNG CANCER: Dropping bars or rising hoops—phase III outcomes of NSCLC

    loading  Checking for direct PDF access through Ovid

Abstract

Over the past three decades, the interpretation of clinical trial outcomes in studies of advanced-stage non-small-cell lung cancer has changed. The robustness of findings from these trials has been called into question. We believe this change is a reflection of the improved understanding of molecular-based therapeutics and continued advances in this field.

Related Topics

    loading  Loading Related Articles